Pembrolizumab Use Supported in Advanced Melanoma

WEDNESDAY, July 22, 2020 -- Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of a BRAF inhibitor (BRAFi) with or without MEK inhibitor (MEKi) therapy, according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news